People
Axovant shares plunged after Hung abruptly resigned as CEO and also stepped down from his seat on the company board of directors.
It took more than 8 months and a series of sweetened offers, but Sanofi was able to close their $11.6B deal to buy Bioverativ without triggering an auction.
Since Emma Walmsley took over leadership at Glaxo, expectations have been both high and hypercritical.
Joseph E. Payne was shown the door as CEO of Arcturus last week - a move that Payne is not taking lightly.
Mr Buccilli commenced with the Company in June 2014 as CFO and was appointed CEO in February 2015.
The 28-year-old CEO of Ascendance Biomedical removed his trousers and injected himself at the BDYHAX conference in Texas.
Juno’s Hans Bishop will take home $287M after Celgene acquired his company.
The short seller and MiMedx CEO Parker “Pete” Petit clearly perceive the event differently.
Shares of Arcturusare down more than 8 percent in morning trading after the company announced it abruptly terminated Joseph E. Payne as president and CEO.
Fitzgerald resigns four months after ex-HHS Secretary Price.
PRESS RELEASES